Safety and Efficacy Study of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The primary objective for this study is to evaluate the efficacy of doxycycline +
ursodeoxycholic acid (UDCA) on disease progression in Transthyretin Amyloidosis (ATTR)
subjects with cardiomyopathy with or without neuropathy.